Crizotinib presented with promising efficacy but for concomitant mutation in next-generation sequencing-identified ROS1-rearranged non-small-cell lung cancer
2021 ◽
2018 ◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. 8541-8541